As founding President & CEO of BioSTL, Donn Rubin has helped lead systemic change for St. Louis, bringing new economic vitality and a transformational entrepreneurial culture that leverages the region’s world-class strengths in innovation, especially the medical and plant biosciences. Rubin has served under Republican and Democratic Governors as a director (and as Chairman, 2005 – 2008) of the Missouri Technology Corporation, charged by the General Assembly with leading the state’s innovation-based economic strategy.
As founding chairman and president of Missouri Cures, Donn led the successful passage of the Missouri Stem Cell Research Amendment to the Missouri Constitution, approved by voters in what the Washington Post called the nation’s “emblematic election” of 2006. Rubin continues to lead Missouri Cures and its education foundation in advancing pro-science policies in Missouri.
During the 1990s, he assisted the post-communist governments of Eastern Europe reform their legal and health systems. He advised the Minister of Justice of Albania, and led pioneering programs in nine Eastern European countries to help reform and improve post-communist health care systems. Donn received his B.S. in Economics, summa cum laude, from the Wharton School of the University of Pennsylvania; and his J.D., cum laude, from the University of Michigan Law School.